Skip to main content

Table 3 Average provider costs (% of total), mean patient costs (95% confidence interval) and financing (% of total), US$*

From: Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa

Average provider costs PWP model PNP model Purely public model
  Site 1 Site 2 Site 3 Site 4 Site 5 Site 6
  N = 95 N = 423 N = 355 N = 50 N = 85 N = 174
Hospital stay** 220 (34%) N.A.†† N.A. N.A. N.A. N.A.
Health clinic visits for monitoring** 14 (2.1%) 18 (2.4%) 23 (9%) 24 (9%) 19 (4%) 20 (3%)
Health clinic visits for DOT** 334 (51%) 301 (40%) 36 (14%) 39 (16%) 426 (84%) 485 (85%)
Visits to 'treatment supporters'** N.A. N.A. 55 (22%) 55 (22%) N.A. N.A.
Sputum smears 12 (1.8%) 14 (1.8%) 16 (7%) 16 (7%) 16 (3%) 16 (3%)
Sputum culture 16 (2.4%) 17 (2.3%) N.A. N.A. N.A. N.A.
Drugs 46 (7%) 383 (52%) 46 (18%) 46 (18%) 46 (9%) 46 (8%)
X-rays 12 (1.8%) 11 (1.5%) N.A. N.A. N.A. N.A.
Overall supervision of community-based programme N.A. N.A. 74 (29%) 72 (28%) N.A. N.A.
Training for community 'treatment supporters' N.A. N.A. 1 (0.4%) 1 (0.4%) N.A. N.A.
Total cost per patient 654 744 251 253 507 568
Mean patient cost       
Visits to clinic for monitoring and DOT       
Travel cost N/A N/A 2.1 (1.7–2.4) 2.6 (2.3–3.2) 26.2 (25.1–27.6) 20.3 (18.6–23.8)
Time cost N/A N/A 6.2 (4.0–8.3) 5.9 (4.6–6.5) 75.6 (71.8–78.2) 101.9 (94.4–115.1)
Visits to 'treatment supporter' for DOT       
Travel cost N/A N/A 0 0 N.A. N.A.
Time cost N/A N/A 30.9 (23.6–36.8) 28.2 (24.9–30.5) N.A. N.A.
Total cost per patient N/A N/A 39.2 (28.3–47.5) 36.7 (31.8–40.2) 101.8 (96.9–105.8) 122.2 (113.0–138.9)
Financing of treatment cost       
Public provider N.A. N.A. 59 (20%) 63 (20%) 445 (73%) 506 (73%)
Private provider 609 (93%) 708 (95%) 121 (42%) 114 (39%) N.A. N.A.
Provincial TB programme 46 (7%) 36 (5%) 71 (24%) 76 (27%) 62 (10%) 62 (9%)
Patient N.A. N.A. 39 (13%) 37 (13%) 102 (17%) 122 (18%)
Total cost per patient 654 744 290 290 609 690
  1. * Cost data from 2001. Average exchange rate prevailing in 2001 US$1 = R8.57.
  2. ** Expected number of visits/hospital days for each site is as follows: 7 hospital days for site 1; 3 visits for monitoring at each site except at site 1 where there are only 2 such visits; 130 visits for DOT (sites 2, 5 and 6), 123 visits for DOT (site 1), and 10 visits for DOT (sites 3 and 4); 120 visits to 'treatment supporter' (sites 3 and 4).
  3. Expected number of diagnostic tests for each site: 4 sputum smears (site 1), 7 sputum smears (site 2), and 4 sputum smears (sites 4–6); 1 sputum culture (sites 1 and 2); 3 X-rays (sites 1 and 2).
  4. †† N.A. = not applicable.
  5. Provincial TB programme covered the cost of drugs in all the sites except in site 2 where a reimbursement on a patient day basis was provided. In addition to the drugs, the programme also covered the cost of diagnostic tests in sites 3–6.